Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial.
about
Therapeutic and prevention strategies against human enterovirus 71 infectionEV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.How to understand the efficacy measurements for enterovirus type 71 vaccine?EV71 vaccine, an invaluable gift for children.Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China.Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers.Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period.Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine.Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months.Progress on the research and development of inactivated EV71 whole-virus vaccines.Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates.Progress on the research and development of human enterovirus 71 (EV71) vaccines.Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.Update on the development of enterovirus 71 vaccines.Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.Epidemiology and etiology of hand, foot, and mouth disease in Fujian province, 2008-2014.Characterization of the enterovirus 71 VP1 protein as a vaccine candidate.Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.A safety study of inactivated Enterovirus 71 vaccine.
P2860
Q28080796-91764FF8-B4B6-458E-BDA3-122E0CA43268Q30383172-3C36AD76-9F50-4ECF-9E77-F85C821CAF38Q33685512-7D3065BD-8598-4BC6-ACF2-CFC4D114804EQ33701681-DEB8B8B5-6AEB-40C1-8B82-7A847DD3D129Q33887710-3909582D-4AA1-407A-8C8B-CA3C20189526Q34033907-FE521696-DF43-4907-9D7F-C85CC74AFA1BQ34540559-38089105-A573-467C-A492-9B3423A589A9Q34820250-0A61EF7B-7F7D-4C13-995A-350CF82AF659Q35053266-C32953F2-31A1-4C75-8FC2-044EE3A35D0EQ35063743-C70A28CD-1AEA-4F4C-B0B7-529CEE6BC5F0Q36978457-43AC296A-1B8A-4970-947C-54C0DB7EC704Q37469307-EC8B3BCD-8F84-4364-9FE8-29E2EED7D57FQ37530094-E91168BC-76AB-4CBA-9607-02A0B6DAB630Q37698087-25DD8D22-9006-4903-847B-110BFDB214F6Q38068107-636DC34F-A5C0-4911-8720-76E136FF9F42Q38195326-656AC457-BB72-4103-BBF6-3A41F178E445Q38225695-4F3FEF34-8E60-42FD-BC09-10C46F45DDD6Q38840182-8B33F10C-CC3B-40F9-B59F-AA548F4EF744Q40376000-7BC481BC-5B7E-4B6E-8ED1-7F06307A4C2BQ40475005-153F496C-5447-4C3E-AB72-5596929EAF29Q42204996-F35A55C4-B150-4740-9F45-711B917E55A8Q43434704-97E8AF4D-0FF5-4452-A417-72C7E2A82011Q46825689-748C3051-57FF-4130-84FE-D9163BEDC381
P2860
Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tolerability and immunogenicit ...... label, phase 1 clinical trial.
@en
type
label
Tolerability and immunogenicit ...... label, phase 1 clinical trial.
@en
prefLabel
Tolerability and immunogenicit ...... label, phase 1 clinical trial.
@en
P2093
P2860
P356
P1476
Tolerability and immunogenicit ...... label, phase 1 clinical trial.
@en
P2093
Fan-Yue Meng
Feng-Cai Zhu
Jing-Xin Li
Xiu-Ling Li
Yun-Tao Zhang
Zheng-Lun Liang
P2860
P304
P356
10.4161/HV.19521
P577
2012-05-01T00:00:00Z